Monopar Therapeutics Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Monopar Therapeutics Inc. (MNPR) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $14.83 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-12
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $14.83K.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $18.44K.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $22.09K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $8.56K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $14.83K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $18.44K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $22.09K 10-K · filed 2026-03-27 |
| 2025-09-30 | $8.56K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $10.35K 10-Q · filed 2025-08-12 |
| 2023-12-31 | $68.00 10-K · filed 2024-03-28 |
| 2022-12-31 | $2.34K 10-K · filed 2023-03-23 |
| 2022-09-30 | $3.40K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $4.63K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $3.40K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |